Mediastinal mass as a rare manifestation of paragonimiasis in a pediatric patient: a case study and examination of diagnostic difficulties - Top-Institutions - MDSpire

Mediastinal mass as a rare manifestation of paragonimiasis in a pediatric patient: a case study and examination of diagnostic difficulties

  • By

  • Shuchun Yang

  • Li Song

  • Qingwei Guo

  • February 16, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Chinese Center for Disease Control and Prevention (China CDC)
    Chinese Center for Disease Control and Prevention (China CDC)

    Beijing, Beijing

    Key Differentiators

    • Infectious Diseases
    • Parasitology
    • Public Health

  • #2

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, Maryland

    Key Differentiators

    • Infectious Diseases
    • Parasitology
    • Immunology

  • #3

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, Seoul

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Pediatrics

  • #4

    Centers for Disease Control and Prevention (CDC), USA
    Centers for Disease Control and Prevention (CDC), USA

    Atlanta, Georgia

    Key Differentiators

    • Infectious Diseases
    • Parasitology
    • Epidemiology

  • #5

    The Hospital for Sick Children (SickKids)
    The Hospital for Sick Children (SickKids)

    Toronto, Ontario

    Key Differentiators

    • Pediatric Infectious Diseases
    • Parasitology
    • Pulmonology

Original Source(s)

Mediastinal mass as a rare manifestation of paragonimiasis in a pediatric patient: a case study and examination of diagnostic difficulties

  • by Shuchun Yang, Li Song, Qingwei Guo

  • February 16, 2026

Related Content

Opportunities and Concerns of Gamified, Extended Reality for Home-Based Motor Rehabilitation for Children With Brain Injury: Qualitative Case Study on Design Elements Related to the Engagement and Fatigue Perspectives

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

The psychological impact of pediatric movement disorders on families: brief report